Radiation Exposure from Medical Imaging: are Doses in the Carcinogenic Range?
Radiation Exposure from Medical Imaging: are Doses in the Carcinogenic Range?
批准号:
7679019
负责人:
REBECCA SMITH-BINDMAN
金额:
$18.16万
依托单位国家:
美国
项目类别:
财政年份:
2008
资助国家:
美国
项目状态:
已结题
起止时间:
2008-09-01 至 2011-08-31
关键词:
AffectAgeAnatomyAreaBreastCaringChestChildClinicClinicalCohort AnalysisDataDatabasesDemographic FactorsDevelopmentDiagnosisDiagnosticDiagnostic ImagingDiscipline of Nuclear MedicineDoseEnrollmentEpidemiologyExposure toFluoroscopyFutureGoalsHealthHealthcare SystemsImageIncidental FindingsIndividualInvestigationIonizing radiationLeadLinkLogistic RegressionsLow Dose RadiationMalignant NeoplasmsMeasuresMedicalMedical ImagingMedicineModelingMorbidity - disease rateOccupational ExposureOrganPatientsPatternPersonsPhasePhysiciansRadiationRadiation DosageRadiation-Induced CancerRadiologic FindingRecordsRelative (related person)Relative RisksResearchRiskScanningSiteSumSurvivorsSymptomsSystemTestingThyroid GlandTimeTranslatingUnited StatesX-Ray Computed Tomographycancer riskcohortdemographicsdosagehigh riskimaging modalityimprovedmedical specialtiesmemberpopulation basedpublic health relevanceroutine caresexstatisticstrend
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): The use of medical imaging has increased dramatically over the last decade, particularly imaging with computed tomography (CT). Integrating CT into routine care has had an extremely positive impact on patient health, and the development of CT is widely considered one of the most important advances in medicine. However, the radiation doses associated with CT are substantial. For example, a chest CT can deliver 50-500 times the radiation dose of a routine chest x-ray. Therefore, along with the increased utilization of CT has come a marked increase in the medical exposure to ionizing radiation. Extensive epidemiological evidence has linked exposure to ionizing radiation with development of radiation-induced cancers, particularly to radiation-sensitive organs, e.g., the thyroid, breast, and hematopoetic systems. The risk to an individual patient is probably relatively small; but many people are exposed annually, with increasingly large exposures per examination from technological advances in imaging and the use of multiple-phase studies. This could translate into many cancer cases resulting directly from the radiation associated with imaging. Additionally, patients who undergo repeated medical imaging, and children who undergo any imaging, may be at particularly high risk. It is important to understand the radiation delivered through medical imaging, so this potential harm of imaging can be weighed against its benefits. Few data are available regarding current exposure to medical radiation in the United States. Understanding exposures to medical radiation is a crucial first step to develop reasonable strategies to minimize unnecessary exposure. The aims of the proposed study are to identify patterns in the utilization of diagnostic medical imaging that involves exposure to ionizing radiation; to quantitatively estimate average annual exposures to ionizing radiation associated with medical imaging and to identify patient and physician factors that are associated with the receipt of particularly high doses of radiation. To pursue these aims, we will conduct a retrospective cohort analysis of patients enrolled in Group Health, a large, mixed-model, nonprofit, healthcare system in Seattle, WA, whose 500,000 members underwent approximately 6.5 million imaging tests between 1993 and 2007. Group Health collects and stores automated data, including detailed clinical records, and the indication and result of all radiological imaging, conducted by physicians of all specialties. Using this large, population-based database, we will describe patterns of diagnostic imaging over time, estimate temporal trends in radiation doses associated with imaging, and determine factors associated with having the highest exposure to medical imaging radiation. Completing these aims will provide quantitative data on the magnitude of the problem of radiation associated with medical imaging. Further, if we validate that Group Health data can be used for such research, future studies will use Group Health data to evaluate the relative risk of cancer associated with ionizing radiation. The ultimate goal of this research is to help keep medical exposure to ionizing radiation to a minimum. PUBLIC HEALTH RELEVANCE: The use of medical imaging has increased dramatically over the last decade, particularly imaging with computed tomography (CT), originally called computerized axial tomography (CAT) scans. Integrating CT into routine care has improved patient health and the development of CT is widely considered one of the most important advances in medicine. However, substantial radiation doses are associated with CT. For example, a chest CT can deliver 50-500 times the radiation dose of a routine chest x-ray. So along with the increased use of CT has come a marked increase in the medical exposure to ionizing radiation. Much epidemiological evidence has linked exposure to ionizing radiation with development of radiation-induced cancers. Little data are available about current exposure to medical radiation in the United States. Understanding exposures to medical radiation is a crucial first step toward developing reasonable strategies to minimize unnecessary exposure. The aims of the proposed study are to identify patterns in the use of diagnostic medical imaging that involves exposure to ionizing radiation; to estimate average annual exposures to ionizing radiation associated with medical imaging; and to identify patient and physician factors associated with receiving particularly high doses of radiation. Subsequent research will quantify the increased relative risk of developing cancer among individuals who have received particularly high doses of radiation from medical imaging. Completing the proposed aims will help measure the problem of radiation associated with medical imaging. The ultimate goal of this research is to help keep medical exposure to ionizing radiation to a minimum. .
期刊论文(2)
专著(0)
科研奖励(0)
会议论文
DOI:
10.1001/archinternmed.2012.2329
发表时间:
2012-07-09
期刊:
ARCHIVES OF INTERNAL MEDICINE
影响因子:
--
作者:
[Smith-Bindman, Rebecca]
通讯作者:
Smith-Bindman, Rebecca
CT DOSE Collaboratory
-
批准号:9229524
-
项目类别:
-
资助金额:$127.15万
-
财政年份:2014
-
负责人:REBECCA SMITH-BINDMAN
-
依托单位:
CT DOSE Collaboratory
-
批准号:8762155
-
项目类别:
-
资助金额:$132.83万
-
财政年份:2014
-
负责人:REBECCA SMITH-BINDMAN
-
依托单位:
CT DOSE Collaboratory
-
批准号:8926906
-
项目类别:
-
资助金额:$113.9万
-
财政年份:2014
-
负责人:REBECCA SMITH-BINDMAN
-
依托单位:
RCT of US versus CT for Patients in the ED with Suspected Renal Colic
-
批准号:8009392
-
项目类别:
-
资助金额:$915.42万
-
财政年份:2010
-
负责人:REBECCA SMITH-BINDMAN
-
依托单位:
Risk of Cancer with Incidental Findings Identified on Ultrasound Imaging
-
批准号:7760617
-
项目类别:
-
资助金额:$17.27万
-
财政年份:2009
-
负责人:REBECCA SMITH-BINDMAN
-
依托单位:
Risk of Cancer with Incidental Findings Identified on Ultrasound Imaging
-
批准号:7660553
-
项目类别:
-
资助金额:$22.02万
-
财政年份:2009
-
负责人:REBECCA SMITH-BINDMAN
-
依托单位:
Radiation Exposure from Medical Imaging: are Doses in the Carcinogenic Range?
-
批准号:7532159
-
项目类别:
-
资助金额:$22.72万
-
财政年份:2008
-
负责人:REBECCA SMITH-BINDMAN
-
依托单位:
Risk of Cancer in Incidental Findings Identified on Ultrasound Imaging
-
批准号:8519346
-
项目类别:
-
资助金额:$12.18万
-
财政年份:2008
-
负责人:REBECCA SMITH-BINDMAN
-
依托单位:
Risk of Cancer in Incidental Findings Identified on Ultrasound Imaging
-
批准号:8294979
-
项目类别:
-
资助金额:$17.27万
-
财政年份:2008
-
负责人:REBECCA SMITH-BINDMAN
-
依托单位:
Risk of Cancer in Incidental Findings Identified on Ultrasound Imaging
-
批准号:7532245
-
项目类别:
-
资助金额:$17.49万
-
财政年份:2008
-
负责人:REBECCA SMITH-BINDMAN
-
依托单位:
Risk of Cancer in Incidental Findings Identified on Ultrasound Imaging
-
批准号:8106399
-
项目类别:
-
资助金额:$17.35万
-
财政年份:2008
-
负责人:REBECCA SMITH-BINDMAN
-
依托单位:
OUTCOMES OF SCREENING MAMMOGRAPHY IN ELDERLY WOMEN
-
批准号:6377844
-
项目类别:
-
资助金额:$12.72万
-
财政年份:1999
-
负责人:REBECCA SMITH-BINDMAN
-
依托单位:
OUTCOMES OF SCREENING MAMMOGRAPHY IN ELDERLY WOMEN
-
批准号:6174416
-
项目类别:
-
资助金额:$12.72万
-
财政年份:1999
-
负责人:REBECCA SMITH-BINDMAN
-
依托单位:
OUTCOMES OF SCREENING MAMMOGRAPHY IN ELDERLY WOMEN
-
批准号:6653157
-
项目类别:
-
资助金额:$12.72万
-
财政年份:1999
-
负责人:REBECCA SMITH-BINDMAN
-
依托单位:
OUTCOMES OF SCREENING MAMMOGRAPHY IN ELDERLY WOMEN
-
批准号:2908805
-
项目类别:
-
资助金额:$12.68万
-
财政年份:1999
-
负责人:REBECCA SMITH-BINDMAN
-
依托单位:
OUTCOMES OF SCREENING MAMMOGRAPHY IN ELDERLY WOMEN
-
批准号:6522599
-
项目类别:
-
资助金额:$12.72万
-
财政年份:1999
-
负责人:REBECCA SMITH-BINDMAN
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位:
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
-
批准号:81973577
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:辛贵忠
-
依托单位:
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
-
批准号:81602908
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:刘括
-
依托单位: